COLL (STOCKS)
Collegium Pharmaceutical, Inc. Common Stock
$34.190000
-0.450000 (-1.30%)
Prev close: $34.640000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Vikram Karnani
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,111.18M
- Employees
- 357
- P/E (TTM)
- 16.96
- P/B (TTM)
- 3.59
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $796.33M |
| Benefits Costs and Expenses | $688.09M |
| Cost Of Revenue | $313.15M |
| Costs And Expenses | $688.09M |
| Gross Profit | $483.18M |
| Operating Expenses | $294.33M |
| Selling, General, and Administrative Expenses | $294.73M |
| Operating Income/Loss | $188.85M |
| Income/Loss From Continuing Operations After Tax | $74.95M |
| Income/Loss From Continuing Operations Before Tax | $108.24M |
| Income Tax Expense/Benefit | $33.29M |
| Income Tax Expense/Benefit, Deferred | -$26.09M |
| Net Income/Loss | $74.95M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $74.95M |
| Net Income/Loss Available To Common Stockholders, Basic | $74.95M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.37 |
| Diluted Earnings Per Share | $2.04 |
| Basic Average Shares | 127,122,481 |
| Diluted Average Shares | 158,657,715 |
| Assets | $1.65B |
| Current Assets | $745.67M |
| Inventory | $42.74M |
| Other Current Assets | $702.93M |
| Noncurrent Assets | $906.29M |
| Fixed Assets | $11.66M |
| Intangible Assets | $614.04M |
| Other Non-current Assets | $280.59M |
| Liabilities | $1.34B |
| Current Liabilities | $434.97M |
| Accounts Payable | $6.83M |
| Wages | $3.61M |
| Other Current Liabilities | $424.53M |
| Noncurrent Liabilities | $904.56M |
| Equity | $312.42M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $312.42M |
| Liabilities And Equity | $1.65B |
| Net Cash Flow From Operating Activities | $331.04M |
| Net Cash Flow From Operating Activities, Continuing | $331.04M |
| Net Cash Flow From Investing Activities | -$52.23M |
| Net Cash Flow From Investing Activities, Continuing | -$52.23M |
| Net Cash Flow From Financing Activities | -$106.35M |
| Net Cash Flow From Financing Activities, Continuing | -$106.35M |
| Net Cash Flow | $172.46M |
| Net Cash Flow, Continuing | $172.46M |
| Comprehensive Income/Loss | $74.41M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $74.46M |
| Other Comprehensive Income/Loss | -$487.00K |
| Other Comprehensive Income/Loss Attributable To Parent | -$460.00K |